Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

Depression Clinical Trial

Official title:

Culturally Adapted Transdiagnostic Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03496350
• Other study ID #: SAHA
• Status: Completed
• Phase: N/A
• Start date: January 7, 2019
• Est. completion date: December 1, 2019

Study information

• Verified date: February 2020
• Source: Linkoeping University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of a culturally adapted internet-administrated cognitive behaviour therapy (ICBT) in Arabic for anxiety and depression

Description:

The study will compare the effect of the intervention against a wait-list control. The intervention tested is based on cognitive behavior therapy delivered over the internet via a secure treatment platform. Participants in the study are recruited from the general public via social media. The intervention is in Arabic.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 59
• Est. completion date: December 1, 2019
• Est. primary completion date: December 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Be above 18 years of age

• Have symptoms of anxiety and/or depression

• Be able to read and write in Arabic

• Have access to computer or smartphone

Exclusion Criteria:

• Suicidal ideation

• Alcohol addiction

• Other major primary psychiatric disorder

• Ongoing psychological treatment

• Recent (during last 4 weeks) change in psychiatric medication

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Depression
• Depressive Disorder

Intervention

Behavioral:
• Internet-delivered CBT
Culturally adapted transdiagnostic internet-delivered CBT in Arabic

Locations

Country	Name	City	State
Sweden	Linköping University	Linköping

Sponsors (1)

Lead Sponsor	Collaborator
Linkoeping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Patient Health Questionnaire (PHQ-9)	The PHQ-9 is a nine-item self-report questionnaire that measures symptoms of depression. It is scored from 0-27 with a higher score reflecting more severe symptoms.	pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment
Primary	Change in Generalised Anxiety Disorder-7-item scale, (GAD-7)	The GAD-7 is a seven-item self-report questionnaire that measures symptoms of anxiety. It is scored from 0-21 with a higher score reflecting more severe symptoms.	pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment
Secondary	Alcohol Use Disorder Identification Test (AUDIT)	Measures alcohol consumption, drinking behaviors, and alcohol-related problems. It is scored from 0-40 with higher scores reflecting more alcohol consumption, drinking behaviors, and alcohol-related problems.	pre-treatment, week 8
Secondary	Insomnia Severity Index (ISI)	Self-reported symptoms of insomnia. It is scored from 0-28 with higher scores reflecting more symptoms of insomnia.	pre-treatment, week 8
Secondary	Impact of Events Scale - Revised (IES-R)	Self-reported symptoms of post-traumatic stress. It is scored from 0-88 where higher scores reflect more symptoms.	pre-treatment, week 8
Secondary	Perceived Stress Scale (PSS)	Self-reported stress-related symptoms. It is scored from 0-56 with higher scores reflecting more symtoms of perceived stress.	pre-treatment, week 8
Secondary	"Brunnsviken Brief Quality of Life Scale" (BBQ)	Self-reported quality of life. The scale is scored from 0-96 with a higher score reflecting higher self-reported quality of life.	pre-treatment, week 8